Pliant Therapeutics

poison pill toxic poison
Biotech

Pliant, Acelyrin take ‘poison pills’ as Concentra buyout looms

With Concentra expanding its stock influence in Pliant and Acelyrin, the two biotechs have shored up their defences against a potential acquisition.
James Waldron Mar 14, 2025 10:01am
cancelled flights

Pliant terminates lung disease trial due to adverse events

Mar 3, 2025 11:30am
pause hold stop delay

Pliant pauses lung fibrosis trial on advice of safety committee

Feb 10, 2025 4:18am
photo of a paraglider in the foreground with the alps in the background

Flagship vet plants CEO roots at Pharming—Chutes & Ladders

Jan 24, 2025 8:30am
Graphic image of a human liver in front of a dark green background

Pliant liver disease med passes high-dose test but doesn't wow

Feb 5, 2024 10:40am
parachute chutes and ladders

Google DeepMind vet to join GSK—Chutes & Ladders

Oct 20, 2023 9:30am